Skip to main content
Year archive

Medartis Holding AG — 2025 filings

All 15 regulatory filings released by Medartis Holding AG (MED) in 2025, sourced directly from the official regulator.

15 Filings
2025 Period
2025 filings (15)
Filing Released Lang
Medartis appoints Peter Hackel as new Chief Financial Officer
Board/Management Information
2025-11-24 English
Medartis appoints Peter Hackel as new Chief Financial Officer
Board/Management Information
2025-11-24 English
Medartis ernennt Peter Hackel zum neuen Finanzchef
Board/Management Information
2025-11-24 German
Medartis delivers 15.3% organic sales growth in H1 and lifts sales guidance for the full-year
Interim / Quarterly Report H1 2025
2025-08-19 English
Medartis delivers 15.3% organic sales growth in H1 and lifts sales guidance for the full-year
Earnings Release H1 2025
2025-08-19 English
Medartis erzielt im ersten Halbjahr ein organisches Umsatzwachstum von 15,3 % und erhöht die Umsatzprognose für das Gesamtjahr
Earnings Release H1 2025
2025-08-19 German
Medartis 2025 half-year results webcast
Report Publication Announcement
2025-07-30 English
Medartis acquires remaining 53% stake in KeriMedical
M&A Activity
2025-07-17 English
Medartis acquires remaining 53% stake in KeriMedical
M&A Activity
2025-07-17 English
Medartis erwirbt restliche 53 % der Anteile an KeriMedical
M&A Activity
2025-07-17 German
Medartis delivers 12% core sales growth in 2024 and improves its core EBITDA margin from 17% to 19%
Earnings Release FY 2024
2025-03-19 English
Medartis delivers 12% core sales growth in 2024 and improves its core EBITDA margin from 17% to 19%
Earnings Release FY 2024
2025-03-18 English
Medartis delivers 12% core sales growth in 2024 and improves its core EBITDA margin from 17% to 19%
Earnings Release FY 2024
2025-03-18 English
Medartis erzielt 2024 ein Kernumsatzwachstum von 12 % und verbessert ihre Kern-EBITDA-Marge von 17 % auf 19 %
Earnings Release FY 2024
2025-03-18 German
Annual Report 2024
Annual Report FY 2024
2025-03-14 English